Ceftriaxone-resistant salmonella enterica serotype Newport, France.
The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 beta-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000-2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.
Institut Pasteur, Paris, France.
Svetlana
S
Egorova
Mohammed
M
Timinouni
Marie
M
Demartin
Sophie A
SA
Granier
Jean M
JM
Whichard
Vartul
V
Sangal
Laëtitia
L
Fabre
Aurélia
A
Delauné
Maria
M
Pardos
Yves
Y
Millemann
Emmanuelle
E
Espié
Mark
M
Achtman
Patrick A D
PA
Grimont
François-Xavier
FX
Weill
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002443:Ceftriaxone / Q000494:pharmacology*; D003132:Commerce; D024881:Drug Resistance, Bacterial / Q000235:genetics; D016521:Electrophoresis, Gel, Pulsed-Field; D005602:France / Q000453:epidemiology; D006801:Humans; D008460:Meat / Q000382:microbiology; D012480:Salmonella Infections / Q000453:epidemiology* / Q000382:microbiology; D019779:Salmonella enterica / Q000145:classification / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D017422:Sequence Analysis, DNA; D012703:Serotyping; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; C103022:beta-lactamase CMY-2; D001618:beta-Lactamases